Li Peng, Fang Qigen, Yang Yanjie, Chen Defeng, Du Wei, Liu Fei, Luo Ruihua
Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Department of Oral Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Oncol. 2021 Mar 4;11:545433. doi: 10.3389/fonc.2021.545433. eCollection 2021.
To analyze the significance of the number of positive lymph nodes in oral squamous cell carcinoma (SCC) stratified by p16. A total of 674 patients were retrospectively enrolled and divided into 4 groups based on their number of positive lymph nodes (0 vs. 1-2 vs. 3-4 vs. ≥5). The Kaplan-Meier method was used to calculate the disease-free survival (DFS) and disease-specific survival (DSS) rates. Cox model was used to evaluate the independent risk factor. p16 showed positivity in 85 patients with a rate of 12.6%. In patients with p16 negativity, the 5-year DFS rates were 52%, 39%, and 21% in patients with 0, 1-2, and 3-4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients developed recurrence within 2 years after operation, the difference was significant; the 5-year DSS rates were 60, 38, and 18% in patients with 0, 1-2, and 3-4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients died within 4-years after operation. The difference was significant. In p16 positivity patients, the 3-year DFS rates were 41% and 17% in patients with 0-2 and ≥3 positive lymph nodes, respectively, the difference was significant; the 3-year DSS rates were 84 and 46% in patients with 0-2 and ≥3 positive lymph nodes, the difference was significant. The number of positive lymph nodes is significantly associated with the survival in oral SCC, its survival effect is not affected by p16 status.
分析按p16分层的口腔鳞状细胞癌(SCC)中阳性淋巴结数量的意义。回顾性纳入674例患者,根据阳性淋巴结数量分为4组(0个vs. 1 - 2个vs. 3 - 4个vs.≥5个)。采用Kaplan - Meier法计算无病生存率(DFS)和疾病特异性生存率(DSS)。使用Cox模型评估独立危险因素。85例患者p16呈阳性,阳性率为12.6%。在p16阴性的患者中,0个、1 - 2个和3 - 4个阳性淋巴结患者的5年DFS率分别为52%、39%和21%,≥5个阳性淋巴结的患者术后2年内均复发,差异有统计学意义;0个、1 - 2个和3 - 4个阳性淋巴结患者的5年DSS率分别为60%、38%和18%,≥5个阳性淋巴结的患者术后4年内均死亡,差异有统计学意义。在p16阳性的患者中,0 - 2个和≥3个阳性淋巴结患者的3年DFS率分别为41%和17%,差异有统计学意义;0 - 2个和≥3个阳性淋巴结患者的3年DSS率分别为84%和46%,差异有统计学意义。阳性淋巴结数量与口腔SCC的生存显著相关,其生存效应不受p16状态的影响。